Annoucements - Business
We are pleased to announce partnership in Indonesia by acquiring majority of shares & management control of PT Citra Pharma Indonesia.
Effective from 1st Dec 2019
This company was founded by Pak Budi, Pak Chan, Pak Freddy & Pak Agus. At present PT Wellesta CPI is led by Pak Freddy Hidajat as President Director. Indonesia is one of the fastest growing pharmaceutical markets in Asia and offers us good opportunity to partner with present MNCs in the country & companies who want to enter Indonesian market.
Our goal is to provide high quality professional services and support provide high quality healthcare products at optimum price to improve health to masses. We foresee this partnership will help accomplish our Vision and Mission through PT Wellesta CPI Healthcare in Indonesia. Our focus would be driven through our dedicated efforts, strong in-market experience, determination and veracity.

Board of Both Companies post Signature

Sales Team Meeting - PT Wellesta CPI

Sales Team Meeting with PT Wellesta CPI T-Shirts
We are pleased to announce the appointment of Sidik Yudhi Rahmawan as Senior Compliance Manager in Wellesta CPI
Effective from 5th April 2021.

Mr. Yudhi started his professional career as a Finance Business Partner at PT. Unilever in 2003. He spent 10 years in Unilever and was last appointed as the Corporate Internal Auditor. Before joining Wellesta CPI, Mr. Yudhi was the Control, Compliance & Risk (CCR) Manager for PT. Pfizer Indonesia since 2012.
Mr. Yudhi holds an MBA in Business Leadership Executive from ITB and majored in Business Management.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr. Yudhi’s expertise will help achieve our Vision & Mission. Mr. Yudhi will report directly to Yohannes Sinaga (Country Manager of PT Wellesta CPI Indonesia), Paul Lim (Country Head of Wellesta Singapore) and Joe P Ganeshguru (Country Head of Malaysia).
We welcome Mr. Yudhi to the Wellesta family and wish him great success in his new position.
Ms. Anggraini Putri has been appointed as Sr. Product Manager for PT. Wellesta CPI, effective from 13th December 2021.
Effective from 13th December 2021.

Ms. Putri started her career as a Marketing Executive in PT Pfizer Indonesia in 2010. Prior to joining Wellesta CPI, Ms Putri’s last position was as the Brand Manager Glargine Family at PT. Sanofi Indonesia since April 2019.
Ms. Putri holds a Master's Degree from Prasetiya Mulya University majoring in Strategic Management and Bachelor's Degree from the University of Indonesia majoring in Public Health Nutrition.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that with Ms. Putri’s expertise will help achieve our Vision & Mission. Ms. Putri will report directly to Marketing Head of PT Wellesta CPI. Ms. Putri will report directly to Marketing Head of PT Wellesta CPI.
We welcome Ms. Putri to the Wellesta family and wish her great success in her new position.
Mr. Bahrain Utama Prawira has been appointed as Jr Product Manager for PT. Wellesta CPI, effective from 15th November 2021.
Effective from 15th November 2021.

Mr. Bahrain started his professional career as a Marketing Activation Officer in PT Bayer Indonesia in 2017. Before joining Wellesta CPI, Mr. Bahrain was the Jr. Product Manager for PT Bayer Indonesia since 2020.
Mr Bahrain holds a Bachelor Degree from University of Indonesia majoring of Science in Biology.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that with Mr. Bahrain’s expertise will help achieve our Vision & Mission. Mr. Bahrain will report directly to Senior Product Manager of PT Wellesta CPI.
We welcome Mr. Bahrain to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of James Pangaribuan as Senior Product Manager in Wellesta CPI
Effective from 2nd August 2021.

Mr. James started his career as Medical Representative in PT. Novell Pharmaceutical Labs. at 2001 and was promoted as Associate Executive Health Care Representative in 2006.
Mr. James has extensive experience in Marketing with more than 12 years in four pharmaceutical companies. In 2009, James appointed as Product Manager in PT Pfizer Indonesia, then he moved to PT Novell Pharmaceutical Laboratories and PT Daewoong Pharmaceutical Company Indonesia in 2012. Prior to joining Wellesta CPI, Mr. James' last position was as the Senior Product Manager at PT Transfarma Medica Indah (Menarini) since 2014.
Mr. James holds a bachelor's degree from University of Sumatera Utara. We at Wellesta are very optimistic about Indonesia Healthcare Market & opportunities for Wellesta to progress.
We are sure that with Mr. James’ expertise will help achieve our Vision & Mission. Mr. James will report directly to Marketing Head of PT. Wellesta CPI. We welcome Mr. James to the Wellesta family and wish him great success in his new position.
Following this change, Ms. Ina Rizki Nurani (Ina) will report to Mr. James effective per August 2nd, 2021.
We are pleased to announce the appointment of Immam Prabudi as Sales & Marketing OTC Manager in Wellesta CPI w.e.f. 1 September, 2021.
Effective from 1 Sep 2021.

Mr. Immam Prabudi has been appointed as Sales & Marketing OTC Manager for PT. Wellesta CPI, effective from 1st September 2021.
Prior to joining Wellesta CPI, Mr Immam’s last position was as the Head of Sales & Trade Marketing at PT Tempo Scan Pacifik Tbk in the Consumer & Cosmetic Division.
Mr Immam started his professional career as a Key Account Representative at PT Unilever in 2004. In 2006, Immam was promoted as Head of Area – West Kalimantan and then as Head of Area- Jakarta in 2008 at PT Nestle Indonesia. In 2010, Immam then joined PT XL Axiata as a Sales Area Manager – Retail Development.
Mr Immam holds a Bachelor’s Degree from USU and majored in Agriculture.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr. Immam’s expertise will help us achieve our Vision & Mission.
Mr. Immam will be based in Jakarta and will report directly to Mr. Paul Lim (OTC lead for Indonesia, Philippines and Singapore) and Mr. Yohannes Sinaga (Country Manager, Indonesia).
We welcome Mr. Immam to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Agus Demak M. Siahaan as National Sales Manager in Wellesta CPI.
Effective from 1st June 2021 .

Mr. Agus has 20 years of extensive experience in Sales & Marketing expertise. He started his career in PT. Pfizer Indonesia as HCR in 1998. He was promoted to the role of District Sales Manager in 2002 and Regional Sales Manager in 2006. Prior to joining PT. Wellesta CPI, Mr. Agus was the Regional Sales Manager at PT. Takeda Indonesia since 2010.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that with Mr. Agus’ expertise will help achieve our Vision & Mission.
Mr. Agus will report directly to Yohannes Sinaga, Country Manager of PT Wellesta CPI Indonesia. We welcome Mr. Agus to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Mr. Slamet Achmad as Product Manager for PT. Wellesta CPI.
Effective from 1st December 2019.

Mr. Slamet started his career at PT Dumex Indonesia as Medical Representative in 1992. In 1997, he then transited to a Medical Representative in PT Pfizer Indonesia. He was promoted to District Sales Manager in 2002 and Product Manager in 2005. In 2015, he joined PT Citra Pharma Indonesia as Product Manager.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr Slamet’s expertise will help achieve our Vision & Mission. Mr Slamet will report directly to Yohannes Sinaga, Country Manager of PT Wellesta CPI Indonesia.
We welcome Mr. Slamet to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Ms. Dini Ika Pratiwi as Jr. Product Manager for PT. Wellesta CPI.
Effective from 25th January 2021.

Ms. Dini started her career at PT. Boehringer Ingelheim Indonesia as part of the Medical Representative Development Program (MRDP) in 2015 and was promoted to Marketing Service Executive/Product Executive in 2017 – 2019. Prior to joining Wellesta CPI, Ms. Dini’s last position was as the Product Manager at Etana Biotechnologies Indonesia since September 2019. Ms. Dini holds a Bachelor’s Degree from Pancasila University and majored in Pharmacy.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Ms Dini’s expertise will help achieve our Vision & Mission. Ms Dini will report to Marketing Head PT Wellesta CPI
We welcome Ms. Dini to the Wellesta family and wish her great success in her new position.
We are pleased to announce the appointment of Mr. Yohannes Sinaga as Country Manager, PT Wellesta CPI Indonesia.
Effective from 1st May 2020.
His last position was Chief Marketing Officer for AstraZeneca Indonesia. He has extensive experience with 15 years in pharmaceutical industry.
Mr. Sinaga has experience in various positions including sales and marketing, as well as various experiences in varied therapeutic areas. He has extensive engagement with Medical Association Groups including the association of Pediatrician, Psychiatry, Internal Medicine, Hematology – Oncology, Surgical Oncology, Pathology, Pulmonology, Hepatology, Nephrology, Virology, Neurology, Rheumatology, Urology, Gynecology, as well as with Government Stakeholders.
Mr. Sinaga’s career started as Product Specialist for Novartis in 2006, then moved to marketing role as a Product Manager, he worked with Novartis for 5 years. In 2011, he decided to move to Roche Indonesia as an Oncology Product Manager, 1 year later was promoted as a Group Product Manager and later was appointed as Business Unit Head. He joined AstraZeneca (AZ) in 2016 as a Business Unit Director for Respiratory Disease as well as to leading Core Products and later to lead the Learning & Development Department. Mr. Sinaga was a member of AstraZeneca International Marketing Excellence Champion with the role to set Respiratory strategy plan to countries in international region.
Mr. Sinaga holds MBA from IPMI International Business School in Jakarta as well as a Certified Pharmacist/Apothecary from University of Padjadjaran Bandung – Indonesia.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr. Sinaga’s leadership the Indonesia team will help achieve our Vision & Mission. Mr. Sinaga will report to Milan Paleja, Director of PT Wellesta CPI Healthcare & also Chairman & MD of Wellesta Group.
We welcome Mr. Yohannes Sinaga to Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Mr. Molden Situmorang as National Sales Manager for PT Wellesta CPI Indonesia.
Effective from 1st Sep 2020

Mr. Molden has experiences in various positions in several Multinational Pharmaceutical Companies with skills in Sales Management and Key Account Management.
He started his career in sales function as a Medical Representative at PT. Eisai Indonesia since 1995 and was then appointed as a Sales Manager in 2004. He then transitioned to PT. Pfizer Indonesia in 2011 as a Sales Manager, then PT. Sandoz Indonesia in 2013 as a Sales Manager and finally to PT. CPI in 2016 as a Sales Manager. His last position was the Key Account Manager at PT. Wellesta CPI in 2020.
Mr. Molden holds a bachelor’s degree in Business Administration from Nommensen University in North Sumatra and continued with a Leadership Development Program from Prasetya Mulya Business School in Jakarta, on a scholarship program from PT. Eisai Indonesia.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr. Molden’s expertise will help achieve our Vision & Mission. Mr. Molden Situmorang will report to Yohannes Sinaga, Country Manager of PT Wellesta CPI Indonesia.
We welcome Mr. Molden to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Mrs. Heny Fitrayanti as Product Manager for PT Wellesta CPI Indonesia.
Effective from 1st Sep 2020

Mrs. Heny’s career goal was to be a marketer, and she has experience in various positions in marketing and business functions at various multinational pharmaceutical companies. She has skills in Marketing Management, Sales Management, Key Accounts and Market Access Management.
Her career started in sales function as a Medical Representative at Servier Indonesia in 1998. She was a Key Account Manager at Bristol Myers Squibb in 2008 and was then appointed as Area Manager at GlaxoSmithKline in 2009. In 2014, Mrs. Heny was a Sales Manager in Novartis Indonesia and transitioned to the role of a Market Access Manager in the commercial department at Eisai Indonesia in 2016. Her last position was Marketing Manager at Eisai Indonesia.
Mrs Heny holds a bachelor’s degree in Business Administration from Stiakin University in Jakarta, and a master’s degree in Management from Bina Nusantara University in Jakarta, on scholarship program from PT Eisai Indonesia.
We at Wellesta are very optimistic about the Indonesian healthcare market and opportunities for Wellesta to progress. We are sure Mrs. Heny’s experience and expertise will help us achieve our vision and mission. Mrs. Heny will report to Marketing Head PT Wellesta CPI.
We welcome Mrs. Heny Fitrayanti to the Wellesta family and wish her great success in her new position.
We are pleased to announce the appointment of Mr. Alimin Chandra as Finance Manager and Business Partner for PT Wellesta CPI Indonesia.
Effective from 3rd August 2020

Mr. Chandra has extensive experience in finance with more than 11 years in 3 MNC pharmaceutical companies. Mr. Chandra has experience in Business Partnering, creating deals and partnerships with local partners, product transfer, and acquisition. His latest product transfer was for AstraZeneca’s AI product during his engagement with Pfizer. He was also in charge of the accuracy and punctuality of Corp. Financial Statement reports.
Mr. Chandra’s career started as Business Analyst for AstraZeneca in 2009 and he was promoted to the role of Associate Business Planning Manager in 2011. In 2012, he then transited to a Finance Planning and Analysis role in Merck Sharp Dohme. In 2015, he joined Pfizer Indonesia as Finance Planning Manager. Mr. Chandra holds a Bachelor's Degree in Computerized Accounting from Bina Nusantara University in Jakarta, and a Master of Management from Pelita Harapan University in Jakarta – Indonesia.
Mr. Chandra will be part of the PT Wellesta CPI leadership team and will support performance analysis, budgeting, and support our growth agenda.
We are sure Mr. Chandra’s experience and expertise will help us achieve our vision and mission. Mr. Chandra will report to Yohannes Sinaga, Country Manager of PT Wellesta CPI Indonesia .
We welcome Mr. Alimin Chandra to the Wellesta family and wish him great success in his new position.
We are pleased to announce the appointment of Mrs. Farida Aryani as HR Business Partner for PT Wellesta CPI Indonesia.
Effective from 21st Sep 2020

Mrs. Farida has 19 years of extensive experience in the Human Resource expertise. She started her career in Makro Cash & Carry as Compensation and Benefit Staff. In 2002, she joined PT Boehringer Ingelheim Indonesia in Payroll, C&B and HRIS, and worked there for 11 years.
In 2013, Mrs. Farida transitioned to PT Novartis Indonesia as Payroll & Time Specialist and was promoted to the C&B lead 3 months later. She was appointed as the Country C&B Lead in 2016 to lead the Compensation and Benefit team for Novartis Group: Novartis Indonesia, Sandoz Indonesia, Ciba Vision Batam and Alcon Pharmaceutical. Before joining Wellesta CPI, Mrs. Farida was the Head of Remuneration for Adira Finance in 2019.
We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mrs. Farida’s expertise will help achieve our Vision & Mission. Mrs. Farida will report directly to Yohannes Sinaga (Country Manager of PT Wellesta CPI Indonesia).
We welcome Mrs. Farida to the Wellesta family and wish her great success in her new position.
No News Found